Product Description
Major Segments Covered in the Breast Tissue Markers and Breast Localization Wires Market Report Suite
In 2015, wire-guided breast localization was the most commonly used method for breast lesion localization in the United States. Though widely used, wire localization is associated with several drawbacks including scheduling difficulties and high re-excision rates. The drawbacks of wire localization have given rise to the development of alternative localization methods. Several leading alternative methods for breast lesion localization include the electromagnetic reflector method (SAVI SCOUT®, Cianna Medical), magnetic tracer localization method (Sentimag®, Endomag), radioactive seed localization (RSL) method and intraoperative ultrasound (IOUS) method. The use of alternative localization methods is expected to increase over the forecast period, cannibalizing unit sales of the breast localization wire market.
The full report suite on this market includes breast tissue markers and breast localization wires.
While this report suite contains all U.S. breast tissue markers and breast localization wire device data, each of the markets are also available as standalone MedCore reports. This allows you to get access to only the market research that you need. You can view all these included reports and segmentation here:
- US Market Report for Breast Localization Wires 2016 – MedCore – In-depth analysis of the Breast Localization Wires market. Chapter includes market growth, ASPs and competitive analysis of the market.
- US Market Report for Breast Tissue Markers 2016 – MedCore – In-depth analysis of the Breast Tissue Markers market. Chapter includes market analysis and forecast, factors that drive and limit the market, as well as, competitive analysis of companies involved in the market.
Breast Tissue Marker and Breast Localization Wire Market Trends
The number of new cases of invasive and in situ female breast cancer in the U.S. is expected to reach about 441,000 by 2030. Growth will be driven by the aging U.S. population, increased mammogram procedure volume and improvement in mammogram quality. The rising volume of diagnoses will drive an increase in the number of patients requiring treatment, applying upward pressure to breast tissue marker unit sales and limiting the decline in breast localization wire unit sales over the forecast period.
This report includes an analysis of other factors and trends that have positively and negatively impacted the market.
Breast Tissue Marker and Breast Localization Wire Market Report Data Types Included
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2022, and Historical Data to 2012
- Market Drivers & Limiters for Each Device Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
- Related Press Releases from Top Competitors
Breast Tissue Marker and Breast Localization Wire Companies Analyzed
Mammotome held the leading position in the U.S. breast tissue marker market in 2015. The increasing use of breast tissue markers for axillary node marking is expected to drive sales for Mammotome over the forecast period. Mammotome acquired the HydroMARK® breast biopsy marker portfolio from Biopsy Sciences in 2014. Hologic was the second leading competitor in the U.S. market for breast tissue markers in 2015. Hologic competes on price, as such, its breast tissue markers are often sold below the ASP of the total breast marker market. The company has lost share in recent years to C. R. Bard and Mammotome.
C. R. Bard held a commanding lead in the U.S. breast localization wire market in 2015. The company is expected to leverage its extensive breast biopsy portfolio and strong relationships with breast centers across the U.S. to maintain the leading position in the breast localization wire market over the forecast period.
Other companies researched in this report includes Argon Medical, Somatex, Cook Medical, Becton Dickinson and more.
History of Our Breast Tissue Marker and Breast Localization Wire Market Research
We’ve been doing market research for medical devices for over a decade. We have built relationships with the top competitors in the breast tissue marker and breast localization wire market so that we can gather proprietary information in confidence to assure more accurate research – that our partners and clients then benefit from.
Because we’re a third party researcher, we have the ability to reach well into the top breast tissue marker and localization wire companies and look at a multi-angle approach to our research. Not only do we consider financial filings, we conduct interviews, use hospital and procedural databases, and our own history of research to create a picture of the market that’s incredibly accurate.
Our clients have used our market research for years to strategize new markets to break into, submit SEC filings, decide sales and marketing strategies, plan acquisitions and product launches, and provide a 3rd party source to show investors, boards, and senior executives.
